3rd Quarter - Report
FRANKLIN SQUARE GROUP, LLC for INTEL CORPORATION
Client
Income
$50,000
Expenses
—
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
health information technology; telehealth
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Immigration IMM
high skilled immigration reform; S 744 comprehensive immigration legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Computer Industry CPI
Cybersecurity; HR 624, CISPA; privacy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Trade (domestic/foreign) TRD
trade secrets issues; S 662, Trade Facilitation and Trade Enforcement Reauthorization Act; trade in services; trade agreements
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Telecommunications TEC
spectrum issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Copyright/Patent/Trademark CPT
International Trade Commission patent issues; HR 845, SHIELD Act; S. 1013, the Patent Abuse Reduction Act; patent litigation reform; AIA implementation; copyright issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA ACKIL | — |
| KARA CALVERT CAMPBELL | — |
| BRIAN PETERS | — |
| MATTHEW TANIELIAN | — |
| RYAN TRIPLETTE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.